# A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.

> **NCT00413894** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 424 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** methoxy polyethylene glycol-epoetin beta [Mircera]

## Key facts

- **NCT ID:** NCT00413894
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 424 (ACTUAL)
- **Last updated:** 2016-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00413894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00413894, "A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00413894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*